Connect with us

Health

WHO recommends use of facemasks as COVID-19 spreads

Published

on

The World Health Organisation has recommended the use of facemasks by the public in specific situations.

The WHO issued the update given the current spread of COVID-19 globally.

The agency notes that masks are recommended following recent exposure to COVID-19, when someone has or suspects they have COVID-19, when someone is at high risk of severe COVID-19, and for anyone in a crowded, enclosed, or poorly ventilated space.

Reports state that 42 new cases of COVID-19 were confirmed from December 31, 2022, to January 13, 2023.

So far, Nigeria has recorded 266,492 COVID-19 confirmed cases; 3,155 deaths, and 259,858 cases have been discharged across 36 states and the Federal Capital Territory.

As of January 13, there have been 661,545,258 confirmed cases of COVID-19, including 6,700,519 deaths, reported to WHO.

In a new release by the WHO, it said, “Previously, the WHO recommendations were based on the epidemiological situation.

“Similar to previous recommendations, WHO advises that there are other instances when a mask may be suggested, based on a risk assessment. Factors to consider include the local epidemiological trends or rising hospitalization levels, levels of vaccination coverage and immunity in the community, and the setting people find themselves in.”

The WHO also advised that a COVID-19 patient could be discharged from isolation early if they tested negative on an antigen-based rapid test.

“Without testing, for patients with symptoms, the new guidelines suggest 10 days of isolation from the date of symptom onset. Previously, WHO advised that patients be discharged 10 days after symptom onset, plus at least three additional days since their symptoms had resolved.

“For those who test positive for COVID-19 but do not have any signs or symptoms, WHO now suggests five days of isolation in the absence of testing, compared to 10 days previously.

“Isolation of people with COVID-19 is an important step in preventing others from being infected. This can be done at home or at a dedicated facility, such as a hospital or clinic,” it noted.

The evidence considered by the organisation showed that people without symptoms were much less likely to transmit the virus than those with symptoms.

“Although of very low certainty, evidence also showed that people with symptoms discharged at day five following symptom onset risked infecting three times more people than those discharged at day 10.”

The WHO also extended its strong recommendation for the use of nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’).

It, however, said pregnant or breastfeeding women with non-severe COVID-19 should consult with their doctor to determine whether they should take the drug, due to ‘likely benefits’ and a lack of adverse events having been reported.

“Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. WHO strongly recommends its use in mild or moderate COVID-19 patients who are at high risk of hospitalisation. In December 2022, the first generic producer of the drug was prequalified by WHO.

“WHO also reviewed the evidence on two other medicines, sotrovimab, and casirivimab-imdevimab, and maintains strong recommendations against their use for treating COVID-19. These monoclonal antibody medicines lack or have diminished activity against the current circulating virus variants.

“There are currently six proven treatment options for patients with COVID-19, three that prevent hospitalisation in high-risk persons and three that save lives in those with severe or critical disease. Except for corticosteroids, access to other drugs remains unsatisfactory globally,” the UN body stated.

Health

FG bans use of foreign syringes, needles in tertiary hospitals 

Published

on

The Federal Government has mandated all Chief Medical Directors (CMDs) and Medical Directors (MDs) of Federal Tertiary Hospitals to procure needles and syringes solely from NAFDAC-approved local manufacturers.

The new directive is contained in a circular addressed to all CMDs and MDs signed by the Minister of State for Health, Dr Tunji Alausa, on Friday.

The minister said that the directive was aimed at boosting domestic production and shielding the country’s manufacturing sector from the influx of foreign goods.

The circular also mandated NAFDAC to stop issuing licences for the importation of foreign manufactured needles and syringes.

Alausa said the health sector had dentified local pharmaceutical industries that produce needles and syringes that were in serious trouble because of the practice.

He also said that out of the nine local pharmaceutical companies that produced needles and syringes eight years ago, six have folded up due to the dumping of largely substandard goods into the market.

“Mr President has directed that this must stop. We all agreed to take the necessary steps to immediately remedy this sad situation.

“Pursuant to this, NAFDAC has been mandated to stop issuing licences for the importation of foreign manufactured needles and syringes.

“It is also to de-list companies involved in the importation of these products going forward,” he said.

Alausa said ”all our tertiary hospitals are hereby directed to procure needles and syringes for your hospital needs from only the NAFDAC-approved local manufacturers listed below are listed either directly or through any of their vendors.

“EL-Salmat Pharmaceuticals Company Ltd Block, Brand Name: Salmaject, HMA Medical Ltd., with brand Name: Deleject and Afrimedical Manufacturing and Supplies Ltd.”

He also listed some of the distributors of the listed companies in some states of the Federation for easy access to assist in making the procurement process easier in the various institutions.

Continue Reading

Health

KDSG trains 180 Red Cross volunteers on Lassa Fever intervention

Published

on

The Kaduna State Ministry of Health has begun a three-day training for 180 Red Cross volunteers on Lassa fever intervention.

The training, which is facilitated by the ministry and funded by the Red Cross, is meant to equip the volunteers selected from 5 LGAs in the state with necessary skills.

The volunteers were drawn from Zaria, Igabi, Kaduna South, Kaduna North and Chikun Divisions.

The State Epidemiologist, Dr Jeremiah Dikwu, said the volunteers were trained with  the knowledge needed to massively intervene during cases of Lassa fever in the state.

He said that the intervention would include Risk Communication and Active Case Search, Psychological First Aid, Rodent Control and Hygiene Promotion for the next 3 months.

Dikwu said the training started  with 30 volunteers on surveillance and would end with the training of 150 volunteers on Risk Communication and Community Engagement .

According to him, Lassa fever is a viral hemorrhagic fever transmitted by rats.

He added that Lassa fever  has been known since the 1950s, but the virus was not identified until 1969, when two missionary nurses died from it in the town of Lassa in Nigeria.

Dikwu added that Lassa fever was caused by a single stranded RNA virus and disseminated systemic primary viral infection.

“The main feature of fatal illness is impaired or delayed cellular immunity leading to fulminant viraemia,” he said

The epidemiologist said that Lassa fever presented  symptoms and signs indistinguishable from those of febrile illnesses such as malaria and other viral hemorrhagic fevers such as Ebola.

“It is difficult to diagnose clinically but should be suspected in patients with fever (e”38°C) not responding adequately to antimalarial and antibiotic drugs.

“The most useful clinical predictors of Lassa fever are fever, pharyngitis, retrosternal pain, and proteinuria for diagnosis; and fever, sore throat, and vomiting for outcome,” Dikwu said.

He said that Ribavirin and general support were needed.

“Ribavirin is almost twice as effective when given intravenously as when taken orally, and if given within six days of the start of illness it may reduce deaths by 90 percent.

“Dehydration, oedema, hypotension, and poor renal function are common; fluid replacement or the use of blood transfusion requires careful monitoring,” he said.

 Dikwu said the volunteers would  be carrying out Risk communication and Community engagement, Active Case Search, Psychological First Aid, Rodent Control and Hygiene Promotion

Continue Reading

Health

Assembly passes Kano Pre-Marital Health Screening Bill

Published

on

Kano State House of Assembly has passed a bill for a law to compel intending couples to undergo HIV, hepatitis and sickle cell anaemia screening before marriage.

The passage followed deliberations in the Committee of the Whole House during plenary session,
presided over by the Speaker, Ismail Falgore on Monday in Kano.

After deliberations, the lawmakers approved the 3rd reading of the bill, read by the Deputy Clerk, Alhaji Nasiru Magaji.

Shortly after passage of the bill, the Majority Leader of the house, Lawan Hussein (NNPP-Dala), stated that “any person
intending to marry shall first submit self for medical examinations.”

He said the bill was considered and passed after the 3rd reading, following various legislative processes.

The leader further said that the bill was passed because the state had been battling with different health issues, including
HIV because people go into marriages without medical screening.

He said that the bill, if signed into law, would save many lives and curb the spread of life-threatening diseases.

“The bill will safeguard the health of citizens by institutionalising pre-marital testing to check the spread of diseases
like hepatitis, HIV and sickle cell anaemia,” he added.

Continue Reading

Trending